DH, K., YI, J., CW, C., CH, K., TW, K., HM, L., & DH, K. (2013). Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells. Dove Medical Press.
Cita Chicago Style (17a ed.)DH, Kim, Jeong YI, Chung CW, Kim CH, Kwak TW, Lee HM, y Kang DH. Preclinical Evaluation of Sorafenib-eluting Stent for Suppression of Human Cholangiocarcinoma Cells. Dove Medical Press, 2013.
Cita MLA (8a ed.)DH, Kim, et al. Preclinical Evaluation of Sorafenib-eluting Stent for Suppression of Human Cholangiocarcinoma Cells. Dove Medical Press, 2013.
Precaución: Estas citas no son 100% exactas.